Search

everythinglearnresearchcommunity

for

Search:↓

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Increasing EGR1 levels makes hair root cells grow faster.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Women with AGA have higher lipid levels, increasing heart disease risk.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.